Tumor Marker Levels Before and After Curative Treatment of Hepatocellular Carcinoma as Predictors of Patient Survival
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Marker Levels Before and After Curative Treatment of Hepatocellular Carcinoma as Predictors of Patient Survival
Authors
Keywords
-
Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 56, Issue 10, Pages 3086-3100
Publisher
Springer Nature
Online
2011-06-26
DOI
10.1007/s10620-011-1796-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A 30-Year, Population-Based Study Shows Improved Management and Prognosis of Hepatocellular Carcinoma
- (2010) Boris Guiu et al. Clinical Gastroenterology and Hepatology
- The changing pattern of epidemiology in hepatocellular carcinoma
- (2010) Helena Nordenstedt et al. DIGESTIVE AND LIVER DISEASE
- Serum Markers of Hepatocellular Carcinoma
- (2010) Giulia Malaguarnera et al. DIGESTIVE DISEASES AND SCIENCES
- Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
- (2010) Masahito Nakano et al. HEPATOLOGY RESEARCH
- AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
- (2010) Kentaroh Yamamoto et al. JOURNAL OF GASTROENTEROLOGY
- Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver
- (2010) Mohamed Abdel-Wahab et al. LANGENBECKS ARCHIVES OF SURGERY
- Time-dependent analysis of predisposing factors for the recurrence of hepatocellular carcinoma
- (2010) Shouta Iwadou et al. LIVER INTERNATIONAL
- Current Approach to Hepatocellular Carcinoma
- (2010) Peter Abrams et al. SURGICAL CLINICS OF NORTH AMERICA
- Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation
- (2010) Akinobu Taketomi et al. TRANSPLANTATION
- Comparing Hepatic Resection and Transarterial Chemoembolization for Barcelona Clinic Liver Cancer (BCLC) Stage B Hepatocellular Carcinoma: Change for Treatment of Choice?
- (2010) Chin-Ta Lin et al. WORLD JOURNAL OF SURGERY
- Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy
- (2009) Kentaroh Yamamoto et al. ANNALS OF SURGICAL ONCOLOGY
- Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment
- (2009) Yasushi Tamura et al. DIGESTIVE DISEASES AND SCIENCES
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
- Prognostic Values of α-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma
- (2009) Hyoung Su Kim et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines
- (2009) Norihiro Kokudo et al. JOURNAL OF GASTROENTEROLOGY
- Prevalence of Subclinical Vitamin K Deficiency in Cholestatic Liver Disease
- (2009) Jennifer Strople et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Biology of Hepatocellular Carcinoma
- (2008) Roberta W. C. Pang et al. ANNALS OF SURGICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now